contrast agent development

Adiposs is a biotech start-up and spin-off from the University of Geneva, incorporated in the Canton of Geneva, Switzerland. It is developing ImageBAT®, a first-in-class contrast agent for brown fat and the first diagnostic imaging product to identify patients with increased risks of cancer progression, higher risk of treatment failure and shorter survival. Its core team consists of four biotech entrepreneurs with over 80 years of combined drug development experience.

Read more

drug developmentmedical imaging